Company Filing History:
1 out of 20 
1 out of 155 
Years Active: 2001-2007
Title: The Innovative Contributions of Ingrid Grummt
Introduction
Ingrid Grummt is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of molecular biology, particularly in the area of RNA polymerase I transcription factors. With a total of 2 patents, her work has implications for understanding cell proliferation and its associated diseases.
Latest Patents
One of her latest patents is focused on the RNA polymerase I transcription factor TIF-IA. This invention relates to proteins whose concentration and activity correlate with cell proliferation rates. It also includes ligands that bind to TIF-IA and compounds that can be used for the prevention or treatment of diseases linked to abnormal cell proliferation. Another notable patent involves an expression vector designed for the permanent expression of foreign DNA. This vector prevents replication in the opposite direction to transcription, facilitating the stable expression of foreign DNA in cells.
Career Highlights
Ingrid Grummt has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts and the Deutsches Krebsforschungszentrum. Her research has significantly advanced the understanding of transcription mechanisms and their roles in cellular processes.
Collaborations
Throughout her career, Ingrid has collaborated with notable colleagues, including Martin Vingron and Friedrich Grummt. These partnerships have enriched her research and contributed to her innovative discoveries.
Conclusion
Ingrid Grummt's work exemplifies the impact of innovative research in molecular biology. Her patents and collaborations highlight her commitment to advancing scientific knowledge and addressing critical health issues.